Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7326 p738
20 November 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Study raises concerns about the risks of high doses of vitamin E

High doses of vitamin E may increase all-cause mortality, a study has shown.

Many clinical trials have tested whether vitamin E supplementation can prevent certain chronic diseases. So researchers at the Johns Hopkins University in Baltimore, Maryland, analysed mortality rates in 19 randomised clinical trials with 135,967 participants.

Their analysis showed an increase in risk of death from all causes. For patients taking high dose vitamin E supplements (>=400IU per day) for at least one year, when compared with placebo, the risk difference was 39 per 10,000 persons (95 per cent confidence interval, 3 to 74 per 10,000 persons, P=0.035). Nine out of 11 trials testing vitamin E doses >= 400IU involved adults with chronic disease and with an average age of 65 years.

The researchers point out that the effects of lower vitamin E doses (<= 300IU) on mortality rates were inconclusive and risks of high vitamin E doses in healthy people are still uncertain. They conclude: “In view of the increased mortality associated with high doses of beta-carotene and now vitamin E, use of any high-dosage vitamin supplements should be discouraged until evidence of efficacy is documented from appropriately designed clinical trials.”

The study is accessible here

Back to Top


©The Pharmaceutical Journal